drugset / Trial / NCT07285278
Phase II Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
Phase 2
Active not recruiting
300 enrolled
Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The primary objective of this study is to evaluate the immunogenicity and safety of 2 injections (approximately 2 months apart) of ABO1108 in adults aged 40 years or above.
Timeline
- Start
- 2025-11-15
- Primary completion
- 2026-03-09
- Completion
- 2027-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABO1108 | Messenger RNA (mRNA) | — | — |